The Development of Endoxifen for Breast Cancer

by Goetz, Matthew P.
Published in Clin Adv Hematol Oncol (2018)

Landscape of Neoadjuvant Therapy for Breast Cancer

by Haddad, Tufia C., Goetz, Matthew P.
Published in Ann Surg Oncol (2015)

Multidisciplinary Management of Breast Cancer With Extensive Regional Nodal Involvement

by Smith, Benjamin D., Goetz, Matthew P., Boughey, Judy C.
Published in J Clin Oncol (2020)

The emerging role of CDK4/6i in HER2-positive breast cancer

by O’Sullivan, Ciara C., Suman, Vera J., Goetz, Matthew P.
Published in Ther Adv Med Oncol (2019)

Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells

by Reinicke, Kathryn E., Kuflel, Mary J., Goetz, Matthew P., Ames, Matthew M.
Published 2009

Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism

by Relling, Mary V., Altman, Russ B., Goetz, Matthew P., Evans, William E.
Published in Lancet Oncol (2010)

Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM

by Goetz, Matthew P., Suman, Vera J., Nakamura, Yusuke, Kiyotani, Kazuma, Jordan, V. Craig, Ingle, James N.
Published in J Clin Oncol (2019)

Pregnancy-Associated Plasma Protein-A Expression in Human Breast Cancer

by Mansfield, Aaron S., Visscher, Daniel W., Hart, Steven N., Wang, Chen, Goetz, Matthew P., Oxvig, Claus, Conover, Cheryl A.
Published in Growth Horm IGF Res (2014)

Re: Concordance Between CYP2D6 Genotypes Obtained From Tumor-Derived and Germline DNA

by Goetz, Matthew P., Brauch, Hiltrud, Ratain, Mark J., Cox, Nancy J., Nakamura, Yusuke, Weinshilboum, Richard, Ingle, James N.
Published in J Natl Cancer Inst (2014)

Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2− node positive breast cancer—A National Cancer Database study

by Peethambaram, Prema P., Hoskin, Tanya L., Day, Courtney N., Goetz, Matthew P., Habermann, Elizabeth B., Boughey, Judy C.
Published in NPJ Breast Cancer (2017)

Tamoxifen Use in Postmenopausal Breast Cancer: CYP2D6 Matters

by Brauch, Hiltrud, Schroth, Werner, Goetz, Matthew P., Mürdter, Thomas E., Winter, Stefan, Ingle, James N., Schwab, Matthias, Eichelbaum, Michel
Published 2013

Development and characterization of novel endoxifen-resistant breast cancer cell lines highlight numerous differences from tamoxifen-resistant models

by Jones, Calley J., Subramaniam, Malayannan, Emch, Michael J., Bruinsma, Elizabeth S., Ingle, James N., Goetz, Matthew P., Hawse, John R.
Published in Mol Cancer Res (2021)

Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo

by Khurana, Ashwani, McKean, Hiedi, Kim, Hyunseok, Kim, Sung-Hoon, Mcguire, Jacie, Roberts, Lewis R, Goetz, Matthew P, Shridhar, Viji
Published 2012

Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy

by Al-Hilli, Zahraa, Choong, Grace, Keeney, Michael G., Visscher, Daniel W., Ingle, James N., Goetz, Matthew P., Jakub, James W.
Published in Breast Cancer Res Treat (2019)

Baseline estrogen levels in postmenopausal women participating in the MAP.3 breast cancer chemoprevention trial

by Richardson, Harriet, Ho, Vikki, Pasquet, Romain, Singh, Ravinder J., Goetz, Matthew P., Tu, Dongsheng, Goss, Paul E., Ingle, James N.
Published in Menopause (2020)

MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

by Choudhery, Sadia, Gomez-Cardona, Daniel, Favazza, Christopher P, Hoskin, Tanya L, Haddad, Tufia C, Goetz, Matthew P, Boughey, Judy C
Published in Acad Radiol (2022)

Phase I study of panobinostat (LBH589) and letrozole in post-menopausal metastatic breast cancer patients

by Tan, Winston W., Allred, Jacob B., Moreno-Aspitia, Alvaro, Northfelt, Donald W., Ingle, James N., Goetz, Matthew P., Perez, Edith A.
Published in Clin Breast Cancer (2015)

Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer

by Haddad, Tufia C., D’Assoro, Antonino, Suman, Vera, Opyrchal, Mateusz, Peethambaram, Prema, Liu, Minetta C., Goetz, Matthew P., Ingle, James N.
Published in Breast Cancer Res Treat (2017)

The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1

by Cairns, Junmei, Ingle, James N., Kalari, Krishna R., Shepherd, Lois E., Kubo, Michiaki, Goetz, Matthew P., Weinshilboum, Richard M., Wang, Liewei
Published in Breast Cancer Res (2019)

CYP2D6 genotype and tamoxifen response

by Rae, James M, Goetz, Matthew P, Hayes, Daniel F, Ingle, James N, Li, Lang, Storniolo, Anna Maria, Stearns, Vered, Flockhart, David A
Published 2005